Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis.
fibrosis
heart failure
hypertrophy
macrophages
monocytes
Journal
Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103
Informations de publication
Date de publication:
03 12 2021
03 12 2021
Historique:
pubmed:
15
10
2021
medline:
8
1
2022
entrez:
14
10
2021
Statut:
ppublish
Résumé
The initial hypertrophy response to cardiac pressure overload is considered compensatory, but with sustained stress, it eventually leads to heart failure. Recently, a role for recruited macrophages in determining the transition from compensated to decompensated hypertrophy has been established. However, whether cardiac resident immune cells influence the early phase of hypertrophy development has not been established. To assess the role of cardiac immune cells in the early hypertrophy response to cardiac pressure overload induced by transverse aortic constriction (TAC). We performed cytometry by time-of-flight to determine the identity and abundance of immune cells in the heart at 1 and 4 weeks after TAC. We observed a substantial increase in cardiac macrophages 1 week after TAC. We then conducted Cite-Seq single-cell RNA sequencing of cardiac immune cells isolated from 4 sham and 6 TAC hearts. We identified 12 clusters of monocytes and macrophages, categorized as either resident or recruited macrophages, that showed remarkable changes in their abundance between sham and TAC conditions. To determine the role of cardiac resident macrophages early in the response to a hypertrophic stimulus, we used a blocking antibody against macrophage colony-stimulating factor 1 receptor (CD115). As blocking CD115 initially depletes all macrophages, we allowed the replenishment of recruited macrophages by monocytes before performing TAC. This preferential depletion of resident macrophages resulted in enhanced fibrosis and a blunted angiogenesis response to TAC. Macrophage depletion in CCR2 (C-C chemokine receptor type 2) knockout mice showed that aggravated fibrosis was primarily caused by the recruitment of monocyte-derived macrophages. Finally, 6 weeks after TAC these early events lead to depressed cardiac function and enhanced fibrosis, despite complete restoration of cardiac immune cells. Cardiac resident macrophages are a heterogeneous population of immune cells with key roles in stimulating angiogenesis and inhibiting fibrosis in response to cardiac pressure overload.
Identifiants
pubmed: 34645281
doi: 10.1161/CIRCRESAHA.121.319737
pmc: PMC8638822
mid: NIHMS1748631
doi:
Substances chimiques
Ccr2 protein, mouse
0
Receptors, CCR2
0
Receptor, Macrophage Colony-Stimulating Factor
EC 2.7.10.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1086-1101Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK122056
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130072
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL155993
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Cell. 2017 Apr 20;169(3):510-522.e20
pubmed: 28431249
J Exp Med. 2018 Feb 5;215(2):423-440
pubmed: 29339450
Front Physiol. 2020 Apr 08;11:301
pubmed: 32322219
JACC Basic Transl Sci. 2018 Mar 14;3(2):230-244
pubmed: 30062209
Circ Res. 2019 Jan 18;124(2):263-278
pubmed: 30582448
Nat Med. 2018 Aug;24(8):1234-1245
pubmed: 29892064
JCI Insight. 2019 Apr 4;4(7):
pubmed: 30779709
Immunity. 2014 Jan 16;40(1):91-104
pubmed: 24439267
Nature. 2017 May 25;545(7655):495-499
pubmed: 28514441
Circulation. 2019 Dec 17;140(25):2089-2107
pubmed: 31661975
PLoS One. 2012;7(5):e36814
pubmed: 22590615
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
J Exp Med. 2017 Nov 6;214(11):3311-3329
pubmed: 28970239
Circulation. 2017 Dec 12;136(24):2359-2372
pubmed: 29021323
Nature. 2007 Mar 22;446(7134):444-8
pubmed: 17334357
J Mol Cell Cardiol. 2017 Jul;108:42-49
pubmed: 27262672
Am J Physiol Regul Integr Comp Physiol. 2010 Jun;298(6):R1597-606
pubmed: 20375266
Genome Biol. 2019 Dec 23;20(1):296
pubmed: 31870423
Circulation. 2020 May 26;141(21):1704-1719
pubmed: 32098504
J Clin Invest. 2013 Jan;123(1):37-45
pubmed: 23281408
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16029-34
pubmed: 25349429
Immunity. 2020 Mar 17;52(3):434-451
pubmed: 32187515
Nat Rev Cardiol. 2018 Jul;15(7):387-407
pubmed: 29674714
Cell. 2020 Oct 1;183(1):94-109.e23
pubmed: 32937105
Proc Natl Acad Sci U S A. 2018 May 15;115(20):E4661-E4669
pubmed: 29712858
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Circulation. 2018 Jul 10;138(2):166-180
pubmed: 29386203
Circulation. 2017 Sep 5;136(10):940-953
pubmed: 28667100
JCI Insight. 2016 Aug 4;1(12):
pubmed: 27536731
J Clin Invest. 2006 Jun;116(6):1547-60
pubmed: 16741575
Science. 2011 May 6;332(6030):687-96
pubmed: 21551058
Immunity. 2019 Jul 16;51(1):131-140.e5
pubmed: 31315031
Circulation. 2020 Aug 4;142(5):466-482
pubmed: 32403949
Circulation. 2015 Apr 21;131(16):1435-47
pubmed: 25901069
Nat Immunol. 2019 Jan;20(1):29-39
pubmed: 30538339
Science. 2009 Jul 31;325(5940):612-6
pubmed: 19644120
FASEB J. 2020 Apr;34(4):5642-5657
pubmed: 32100368
Blood. 2010 Nov 11;116(19):3955-63
pubmed: 20682855
Circulation. 2016 Jul 12;134(2):153-67
pubmed: 27364164